Growth Metrics

Baxter International (BAX) Operating Income (2016 - 2024)

Baxter International (BAX) has disclosed Operating Income for 16 consecutive years, with $959.0 million as the latest value for Q4 2024.

  • On a quarterly basis, Operating Income rose 48.45% to $959.0 million in Q4 2024 year-over-year; TTM through Dec 2024 was $3.2 billion, a 354.03% increase, with the full-year FY2025 number at -$308.0 million, down 2300.0% from a year prior.
  • Operating Income was $959.0 million for Q4 2024 at Baxter International, down from $1.0 billion in the prior quarter.
  • In the past five years, Operating Income ranged from a high of $1.0 billion in Q3 2024 to a low of -$2.9 billion in Q3 2022.
  • A 5-year average of $201.9 million and a median of $360.5 million in 2020 define the central range for Operating Income.
  • Peak YoY movement for Operating Income: plummeted 1456.52% in 2022, then surged 6164.71% in 2024.
  • Baxter International's Operating Income stood at $406.0 million in 2020, then tumbled by 94.33% to $23.0 million in 2021, then tumbled by 1456.52% to -$312.0 million in 2022, then skyrocketed by 307.05% to $646.0 million in 2023, then soared by 48.45% to $959.0 million in 2024.
  • Per Business Quant, the three most recent readings for BAX's Operating Income are $959.0 million (Q4 2024), $1.0 billion (Q3 2024), and $1.0 billion (Q2 2024).